The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Curis, Inc(NASDAQ:CRIS) 
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include CA-4948, an oral small molecule drug candidate, which is in Phase I clinical trial for the treatment o...
Website: http://www.curis.com
Founded: 2000
Full Time Employees: 28
Sector: Healthcare
Industry: Biotechnology
Curis Days Payable Outstanding ttm (DPO)
Curis Days Receivable Outstanding ttm (DSO)
Curis Days Inventory Outstanding ttm (DIO)
Curis Op Cashflow Per Share ttm
Curis Free Cashflow Per Share ttm
Curis Cash Per Share ttm
Curis P/S ratio ttm
Curis (GAAP) P/E ratio ttm
Curis P/B ratio ttm
No extra charts and metrics for this ticker.